{"id":"NCT04144413","sponsor":"Santen SAS","briefTitle":"3-year Study in Dry Eye Disease Patients With Severe Keratitis Receiving Ikervis速 (1mg/mL Ciclosporin)","officialTitle":"A Phase IIIb, Prospective, Interventional, Multicentre, 3-year Study to Explore the Long-term Evolution of Sign and Symptoms, and Occurence of Complications in Dry Eye Patients With Severe Keratitis Receiving Ikervis速 (1mg/mL Ciclosporin)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-05-31","primaryCompletion":"2023-07-14","completion":"2023-07-14","firstPosted":"2019-10-30","resultsPosted":"2024-08-28","lastUpdate":"2024-08-28"},"enrollment":350,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Dry Eye Disease With Severe Keratitis"],"interventions":[{"type":"DRUG","name":"Open-label Ikervis","otherNames":[]},{"type":"DRUG","name":"Masked Ikervis","otherNames":[]},{"type":"OTHER","name":"Vehicle Comparator: Masked Vehicle","otherNames":[]}],"arms":[{"label":"Period 1 Open-label Ikervis","type":"EXPERIMENTAL"},{"label":"Period 2 Masked Ikervis","type":"EXPERIMENTAL"},{"label":"Period 2 Masked Vehicle","type":"OTHER"}],"summary":"The proposed 36-month Post Approval Efficacy Study (PAES) is a prospective, interventional, multicentre study to explore the long-term evolution of signs and symptoms, and occurrence of complications in Dry Eye Disease (DED) patients with severe keratitis receiving Ikervis速 (1mg/mL ciclosporin) eye drops administered once daily","primaryOutcome":{"measure":"The Correlation Between Mean Change From Baseline in Corneal Fluorescein Staining (CFS) Score and Symptom Assessment iN Dry Eye (SANDE) Symptoms Score at Each Visit.","timeFrame":"Months 3, 6, 9, and 12","effectByArm":[{"arm":"Period 1 Open-Label Treatment Ikervis","deltaMin":0.169,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":45,"countries":["Czechia","France","Italy","Poland","Russia","Spain","Turkey (T端rkiye)"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":344},"commonTop":["Eye irritation","Dry Eye","COVID-19","Eye pain","Eye pruritus"]}}